Position
Renaissance Technologies in Cabaletta Bio, Inc.
Back to the book · All holders of CABA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $644.8K$2.69 → $3.11
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.52M | $3.33M | — | — | — | 0.0% |
| Q1 2026 | 2.04M | $5.48M | $2.69 | $761.3K | $1.38M | 0.0% |
| Q2 2026 | 1.54M | $4.77M | $3.11 | $644.8K | −$1.35M | 0.0% |